National Cancer Institute; Notice of Closed Meetings, 22539-22540 [2015-09236]
Download as PDF
Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices
Countermeasure without geographic
limitation.
Liability immunity is afforded to
manufacturers and distributors without
regard to whether the countermeasure is
used by or administered in any
designated geographic area; liability
immunity is afforded to program
planners and qualified persons when
the countermeasure is used by or
administered in any designated
geographic area, or the program planner
or qualified person reasonably could
have believed the recipient was in that
geographic area.
XII. Effective Time Period
and Services Administration (‘‘HRSA’’),
within the Department of Health and
Human Services. Information about the
CICP is available at the toll free number
1–855–266–2427 or https://
www.hrsa.gov/cicp/.
the Secretary, Assistant Secretary for
Financial Resources, Office of Grants
and Acquisition Policy and
Accountability, Office of Acquisition
Policy at 202–690–6361 or
Lori.Sakalos@hhs.gov.
XV. Amendments
Dated: April 16, 2015.
Angela Billups
Associate Deputy Assistant Secretary for
Acquisition, Senior Procurement Executive,
Assistant Secretary for Financial Resources,
Office of the Secretary.
42 U.S.C. 247d–6d(b)(4)
Any amendments to this Declaration
will be published in the Federal
Register.
[FR Doc. 2015–09415 Filed 4–21–15; 8:45 am]
Authority: 42 U.S.C. 247d–6d.
BILLING CODE 4150–28–P
Dated: April 9, 2015.
Sylvia M. Burwell,
Secretary.
42 U.S.C. 247d–6d(b)(2)(B)
[FR Doc. 2015–09412 Filed 4–21–15; 8:45 am]
Liability immunity for Covered
Countermeasures begins on the effective
date and extends for twelve (12) months
from that date.
BILLING CODE 4150–03–P
XIII. Additional Time Period of
Coverage
I have determined that an additional
twelve (12) months of liability
protection is reasonable to allow for the
manufacturer(s) to arrange for
disposition of the Covered
Countermeasure, including return of the
Covered Countermeasures to the
manufacturer, and for Covered Persons
to take such other actions as are
appropriate to limit the administration
or use of the Covered Countermeasures.
Covered Countermeasures obtained
for the Strategic National Stockpile
(‘‘SNS’’) during the effective period of
this Declaration are covered through the
date of administration or use pursuant
to a distribution or release from the
SNS.
XIV. Countermeasures Injury
Compensation Program
asabaliauskas on DSK5VPTVN1PROD with NOTICES
42 U.S.C 247d–6e
The PREP Act authorizes a
Countermeasures Injury Compensation
Program (‘‘CICP’’) to provide benefits to
certain individuals or estates of
individuals who sustain a covered
serious physical injury as the direct
result of the administration or use of the
Covered Countermeasures, and benefits
to certain survivors of individuals who
die as a direct result of the
administration or use of the Covered
Countermeasures. The causal
connection between the countermeasure
and the serious physical injury must be
supported by compelling, reliable, valid,
medical and scientific evidence in order
for the individual to be considered for
compensation. The CICP is
administered by the Health Resources
VerDate Sep<11>2014
18:00 Apr 21, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Assistant
Secretary for Financial Resources, Office
of Grants and Acquisition Policy and
Accountability, Division of Acquisition,
Department of Health and Human
Services.
ACTION: Notice of Public Availability of
FY 2014 Service Contract Inventories.
AGENCY:
In accordance with Section
743 of Division C of the Consolidated
Appropriations Act of 2010 (Public Law
111–117), Department of Health and
Human Services (HHS) is publishing
this notice to advise the public of the
availability of its FY 2014 Service
Contract Inventory. This inventory
provides information on service contract
actions over $25,000 that were made in
FY 2014. The information is organized
by function to show how contracted
resources are distributed throughout the
agency. The inventory has been
developed in accordance with guidance
issued on November 5, 2010 and
December 19, 2011 by the Office of
Management and Budget’s Office of
Federal Procurement Policy (OFPP).
OFPP’s guidance is available at https://
www.whitehouse.gov/sites/default/files/
omb/procurement/memo/servicecontract-inventories-guidance11052010.pdf. HHS has posted its
inventory and a summary of the
inventory on the HHS homepage at the
following link: https://www.hhs.gov/
grants/servicecontracts/.
FOR FURTHER INFORMATION CONTACT:
Questions regarding the service contract
inventory should be directed to Lori
Sakalos, Director in the HHS/Office of
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Public Availability of the Department of
Health and Human Services FY 2014
Service Contract Inventory
42 U.S.C. 247d–6d(b)(3)(B) and (C)
22539
Sfmt 4703
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI EDRN
Review I.
Date: June 9, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Delia Tang, MD, Scientific
Review Officer, Research Programs Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W602, Rockville, MD
20850, 240–276–6456 tangd@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; NCI
Subcommittee F-Institutional Training and
Education.
Date: June 9, 2015.
Time: 11:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W606, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Timothy C. Meeker, Ph.D.,
MD, Scientific Review Officer, Resource and
Training Review Branch, Division of
E:\FR\FM\22APN1.SGM
22APN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
22540
Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W606, Rockville, MD 20850, 240–
276–6464, meekert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Exploratory/Development Research Grant
Program Omnibus SEP–6.
Date: June 9–10, 2015.
Time: 4:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Dona Love, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W236, Rockville, MD
20850, 240–276–5264, donalove@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI EDRN
Review II.
Date: June 9–10, 2015.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Delia Tang, MD, Scientific
Review Officer, Research Programs Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W602, Rockville, MD
20850, 240–276–6456, tangd@mail.nih.gov.
Name of Committee: National Cancer
Institute special Emphasis Panel;
Exploratory/Development Research Grant
Program Omnibus SEP–3.
Date: June 29–30, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Viatcheslav A.
Soldatenkov, Ph.D., MD, Scientific Review
Officer, Special Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W254, Rockville, MD 20850, 240–
276–6378, soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus
SEP–13 Review.
Date: July 9, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: David G. Ransom, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W124,
Rockville, MD 20850, 240–276–6351,
david.ransom@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus
SEP–11 Review.
VerDate Sep<11>2014
18:00 Apr 21, 2015
Jkt 235001
Date: July 15, 2015.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W122, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Shakeel Ahmad, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W122,
Rockville, MD 20850, 240–276–6349,
ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus Drug Development SEP–9.
Date: July 21, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Timothy C. Meeker, MD,
Ph.D., Scientific Review Officer, Resource
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W624, Rockville, MD 20850, 240–
276–6464, meekert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus
SEP–17 Review.
Date: July 21, 2015.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W610, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Caterina Bianco, MD,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W610, Rockville, MD 20850, 240–
276–6459, biancoc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 16, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–09236 Filed 4–21–15; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA RM13–
006: Pioneer Awards.
Date: May 6–8, 2015.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Arnold Revzin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146,
MSC 7806, Bethesda, MD 20892, (301) 435–
1153, revzina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Auditory Neuroscience.
Date: May 7–8, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20895,
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 16, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–09237 Filed 4–21–15; 8:45 am]
BILLING CODE 4140–01–P
Frm 00068
Fmt 4703
Sfmt 9990
E:\FR\FM\22APN1.SGM
22APN1
Agencies
[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)]
[Notices]
[Pages 22539-22540]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09236]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI EDRN Review I.
Date: June 9, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Delia Tang, MD, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W602, Rockville, MD 20850, 240-276-6456 tangd@mail.nih.gov.
Name of Committee: National Cancer Institute Initial Review
Group; NCI Subcommittee F-Institutional Training and Education.
Date: June 9, 2015.
Time: 11:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W606, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Timothy C. Meeker, Ph.D., MD, Scientific Review
Officer, Resource and Training Review Branch, Division of
[[Page 22540]]
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W606, Rockville, MD 20850, 240-276-6464,
meekert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Exploratory/Development Research Grant Program Omnibus SEP-6.
Date: June 9-10, 2015.
Time: 4:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Dona Love, Ph.D., Scientific Review Officer,
Special Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236,
Rockville, MD 20850, 240-276-5264, donalove@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI EDRN Review II.
Date: June 9-10, 2015.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Delia Tang, MD, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W602, Rockville, MD 20850, 240-276-6456, tangd@mail.nih.gov.
Name of Committee: National Cancer Institute special Emphasis
Panel; Exploratory/Development Research Grant Program Omnibus SEP-3.
Date: June 29-30, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Viatcheslav A. Soldatenkov, Ph.D., MD,
Scientific Review Officer, Special Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, MD 20850, 240-276-6378,
soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus SEP-13 Review.
Date: July 9, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: David G. Ransom, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W124, Rockville, MD 20850, 240-276-6351,
david.ransom@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus SEP-11 Review.
Date: July 15, 2015.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W122, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W122, Rockville, MD 20850, 240-276-6349, ahmads@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus Drug Development SEP-9.
Date: July 21, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review
Officer, Resource and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W624, Rockville, MD 20850, 240-276-6464,
meekert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus SEP-17 Review.
Date: July 21, 2015.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W610, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W610, Rockville, MD 20850, 240-276-6459,
biancoc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 16, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-09236 Filed 4-21-15; 8:45 am]
BILLING CODE 4140-01-P